| Bioactivity | AS2034178 free base, a specific and orally active GPR40 agonist, exhibits glucose-dependent insulin secretion enhancement. AS2034178 free base has potential for type 2 diabetes mellitus research[1]. |
| Name | AS2034178 free base |
| CAS | 1030846-42-4 |
| Formula | C27H29FN2O3 |
| Molar Mass | 448.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tanaka H, et al. Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion. J Pharmacol Exp Ther. 2013;346(3):443-452. |
AS2034178 free base
CAS: 1030846-42-4 F: C27H29FN2O3 W: 448.53
AS2034178 free base, a specific and orally active GPR40 agonist, exhibits glucose-dependent insulin secretion enhancemen
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.